Dr. Vincent Philippe Lavallée

Assistant Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Vincent Philippe Lavallée. Improve your application with a focused, well-structured draft.

Biography

Vincent-Philippe Lavallée is an Assistant Professor at the Université de Montréal, specializing in pediatric hematology and oncology. His research focuses on the genomic and cellular determinants affecting pediatric cancers to enhance precision diagnostics and identify vulnerabilities in treatment. He leads several projects investigating acute myeloid leukemia and other blood disorders using innovative approaches such as single-cell RNA sequencing (scRNA-seq) and in-depth genomic analysis. Notably, he examines mechanisms of relapse and strives to find novel prognostic biomarkers in pediatric oncology. He is affiliated with various funding sources including the Fonds de recherche du Québec - Santé and the Canadian Institutes of Health Research. As a proponent of integrating non-invasive techniques into pediatric oncology, Lavallée seeks to improve outcomes through his research initiatives and clinical applications. His work contributes to the greater understanding and treatment of complex hematological diseases and advancing the field of precision medicine.

Research Interests

Experience

Assistant Professor

2024-01-01 — Present

Université de Montréal • Montréal, QC, Canada

Engaged in teaching and supervising graduate students in the field of pediatric oncology.

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.